Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells
about
Energy metabolic dysfunction as a carcinogenic factor in cancer cellsRole of multifaceted regulators in cancer glucose metabolism and their clinical significanceMolecular magnetic resonance imaging in cancerEffect of Dietary ω-3 Polyunsaturated Fatty Acid DHA on Glycolytic Enzymes and Warburg Phenotypes in CancerIntegrating canonical and metabolic signalling programmes in the regulation of T cell responsesHow does the metabolism of tumour cells differ from that of normal cellsPPP2R5C Couples Hepatic Glucose and Lipid HomeostasisOxidative stress, a trigger of hepatitis C and B virus-induced liver carcinogenesisReexamining cancer metabolism: Lactate production for carcinogenesis could be the purpose and explanation of the Warburg effectPoor prognosis of hexokinase 2 overexpression in solid tumors of digestive system: a meta-analysis.A joint analysis of transcriptomic and metabolomic data uncovers enhanced enzyme-metabolite coupling in breast cancer.Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer.FOXM1 promotes the warburg effect and pancreatic cancer progression via transactivation of LDHA expressionDysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertensionLong term effect of curcumin in regulation of glycolytic pathway and angiogenesis via modulation of stress activated genes in prevention of cancerMetabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples.JMJD2A promotes the Warburg effect and nasopharyngeal carcinoma progression by transactivating LDHA expressionTargeting Epstein-Barr virus oncoprotein LMP1-mediated glycolysis sensitizes nasopharyngeal carcinoma to radiation therapy.Targeting hypoxia in the leukemia microenvironmentVisual gene-network analysis reveals the cancer gene co-expression in human endometrial cancerTAp73 promotes anti-senescence-anabolism not proliferation.miR-290/371-Mbd2-Myc circuit regulates glycolytic metabolism to promote pluripotency.TRIM24 links glucose metabolism with transformation of human mammary epithelial cellsGlucose modulation induces reactive oxygen species and increases P-glycoprotein-mediated multidrug resistance to chemotherapeutics.PIM1 regulates glycolysis and promotes tumor progression in hepatocellular carcinomaSIRT5 regulation of ammonia-induced autophagy and mitophagy.Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-D-glucose.Metformin Treatment for the Prevention and/or Treatment of Breast/Mammary TumorigenesisHypoxia inducible factor 1α expression and effects of its inhibitors in canine lymphomaSerum Metabolomics to Identify the Liver Disease-Specific Biomarkers for the Progression of Hepatitis to Hepatocellular Carcinoma.Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expressionMicrotargeting cancer metabolism: opening new therapeutic windows based on lipid metabolismPTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.p53-Dependent regulation of metabolic function through transcriptional activation of pantothenate kinase-1 gene.Metabolic host responses to infection by intracellular bacterial pathogensMutant Kras- and p16-regulated NOX4 activation overcomes metabolic checkpoints in development of pancreatic ductal adenocarcinoma.Translational medicine as a new clinical tool and application which improves metabolic diseases: perspectives from 2012 Sino-American symposium on clinical and translational medicine.Targeting VDAC-bound hexokinase II: a promising approach for concomitant anti-cancer therapy.MUC1: a novel metabolic master regulator.Membrane transporters for the special amino acid glutamine: structure/function relationships and relevance to human health.
P2860
Q26751065-B2D32915-E91B-4A15-B3B4-39AC967AB5EDQ26765039-66C84F71-A5BA-433A-B46D-E39CB22AF0BEQ26782151-A8401C2E-DE31-4DA5-87FE-9219F4656835Q26784557-03E8D2C0-E199-4905-9A5E-C4866EB2903DQ26851446-40DCE025-8830-4D1A-AB38-0DD9C6982DA6Q27011856-B3D29A3B-775D-44F0-A15A-1C98F030D3D6Q27310235-F9845EEE-DA5A-4A35-9C1D-D249AE0C9C03Q28075646-6412BE26-7B3A-4C89-BF08-5457C03BCC42Q28077883-594379F7-F26F-4DBA-AEA2-A737529333D3Q30234765-3F1F8223-FA60-42A5-B005-DFC8E19CB574Q31114185-6BD4B8C6-2227-4786-84F0-B587D2A8534EQ33598925-9C019C67-9516-4F4F-9069-99BA58F269F6Q33624900-E921D931-AE8E-48D5-8C87-75E6848AD073Q33738642-493F77FF-D554-4234-8E97-0722FF3EA64DQ33763348-19ED3022-2E84-4945-96E9-DCDD4291951CQ33844930-DF7FA46F-7AC0-43C8-BC19-2F8D1B2BCC66Q33892580-07C61087-A159-46F9-A9F0-ECF87D9C8290Q34171822-38F48AFC-72F1-4FFC-90FF-397B70C2F193Q34401785-C87FA748-0249-4BE1-8576-70CFF153FEC5Q34525508-322DF048-CBB8-4F33-A671-F40B79E438C4Q34774270-15299078-7EE2-43CC-B565-63B614357CEBQ35192732-F84E6E9C-DC86-4BB5-B3C0-56D13A4EECF0Q35209056-CA8F052E-DF03-41E2-B513-4D35CD8736C1Q35538527-B0B986F4-6751-4B5C-8722-B5CD9144BFAEQ35793653-2C52D2E5-901B-4A96-B730-187207E6BFC6Q35852924-4692F086-6267-4AE0-8D26-BD7F8C4E30CBQ36061450-1E52FEC4-B36C-44E7-A92A-D9F1BD3ACBBAQ36078840-44F1D27A-2314-4428-8B6D-B7E9D98F5FDDQ36341443-476AD5D7-6C62-4AF0-955F-EDC88F036DD9Q36360941-F8318D97-2D26-42FD-B848-62A2015F4F95Q36413397-24D9D90C-E25E-4540-8BF6-C66FF4E63ED6Q36503853-DBE80EF0-3AB4-4810-B579-1FE039E74CACQ36562237-5C032247-01B2-4010-95C7-5D7370D4AB3BQ36724268-0E46A02A-3AFA-4132-B5CE-5CEBC6CB7457Q36994631-FC3B07CC-B73D-4E9E-8725-EBCF887E529DQ37676353-EA6226CA-502C-45E4-BD08-DC8151D1B169Q37717478-A453F5FA-019F-4808-BAA3-CD17161A9595Q38132274-80386E2B-F82D-4C06-8EBC-1AD6824D7AA3Q38177983-FEDA064E-49FF-496C-81D1-11F3C8B2FF7DQ38243334-07042B94-462D-4795-8F56-5C5FB54B8A99
P2860
Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Dysregulation of glucose trans ...... or suppressors in cancer cells
@ast
Dysregulation of glucose trans ...... or suppressors in cancer cells
@en
Dysregulation of glucose trans ...... or suppressors in cancer cells
@nl
type
label
Dysregulation of glucose trans ...... or suppressors in cancer cells
@ast
Dysregulation of glucose trans ...... or suppressors in cancer cells
@en
Dysregulation of glucose trans ...... or suppressors in cancer cells
@nl
prefLabel
Dysregulation of glucose trans ...... or suppressors in cancer cells
@ast
Dysregulation of glucose trans ...... or suppressors in cancer cells
@en
Dysregulation of glucose trans ...... or suppressors in cancer cells
@nl
P3181
P1476
Dysregulation of glucose trans ...... or suppressors in cancer cells
@en
P2093
Jin-Qiang Chen
Jose Russo
P304
P3181
P356
10.1016/J.BBCAN.2012.06.004
P407
P577
2012-12-01T00:00:00Z